Clinical Trials Browser

Phase 1/2 × Multiple Myeloma × Positron Emission Tomography Computed Tomography × Clear all

NCT03665155 2021-07-30

First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody

Phase 1/2 Completed

11 enrolled 11 charts

Multiple Myeloma